These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7936219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of positron emission tomography in the assessment of human neurotransplantation.
    Sawle GV, Myers R.
    Trends Neurosci; 1993 May; 16(5):172-6. PubMed ID: 7685938
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients.
    Remy P, Samson Y, Hantraye P, Fontaine A, Defer G, Mangin JF, Fénelon G, Gény C, Ricolfi F, Frouin V.
    Ann Neurol; 1995 Oct; 38(4):580-8. PubMed ID: 7574454
    [Abstract] [Full Text] [Related]

  • 8. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
    Sawle GV, Bloomfield PM, Björklund A, Brooks DJ, Brundin P, Leenders KL, Lindvall O, Marsden CD, Rehncrona S, Widner H.
    Ann Neurol; 1992 Feb; 31(2):166-73. PubMed ID: 1575455
    [Abstract] [Full Text] [Related]

  • 9. Fetal brain grafts and Parkinson's disease.
    Science; 1990 Dec 07; 250(4986):1434-5. PubMed ID: 2255915
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neural transplantation as a therapy for Parkinson's disease.
    Olanow CW, Freeman TB, Kordower JH.
    Adv Neurol; 1997 Dec 07; 74():249-69. PubMed ID: 9348419
    [No Abstract] [Full Text] [Related]

  • 13. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations.
    Mendez I, Dagher A, Hong M, Hebb A, Gaudet P, Law A, Weerasinghe S, King D, Desrosiers J, Darvesh S, Acorn T, Robertson H.
    J Neurosurg; 2000 May 07; 92(5):863-9. PubMed ID: 10794303
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.
    Rakshi JS, Uema T, Ito K, Bailey DL, Morrish PK, Ashburner J, Dagher A, Jenkins IH, Friston KJ, Brooks DJ.
    Brain; 1999 Sep 07; 122 ( Pt 9)():1637-50. PubMed ID: 10468504
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
    Kordower JH, Freeman TB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA, Snow B, Olanow CW.
    Mov Disord; 1998 May 07; 13(3):383-93. PubMed ID: 9613726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.